Screening takes about twenty minutes and is almost entirely a blood test. Early prostate cancer has no symptoms at all — which is exactly why waiting for one is the wrong plan. Here is what screening involves, when to start, and what it costs.
Prostate cancer is the most frequently diagnosed cancer among Kenyan men, accounting for roughly one in seven male cancer cases nationally. Caught while it is still confined to the gland, it is highly treatable. The difficulty is that Kenyan hospital studies consistently find the large majority of men arriving only once the disease has reached an advanced stage — by which point the options narrow sharply. Screening exists for one reason: to move that moment earlier.
Men of African descent develop prostate cancer earlier and more aggressively than the global average. International guidelines written for other populations start later than is sensible here.
Your father or a brother has had prostate cancer, or you have a wider family history of prostate or breast cancer. A baseline PSA at 40 gives every future test something to compare against.
All Kenyan men, regardless of family history. African ancestry alone is a recognised risk factor, and it is the reason we do not simply copy the age-55 guidance used elsewhere.
From 50, annual PSA testing is standard for most men. What matters is not a single reading but the trend across years — a rising number tells a story a one-off test cannot.
Most men picture the examination and stop reading. Here is the honest sequence, start to finish.
A specialist urologist takes your history — symptoms, family history, medication. This is where your personal risk gets established, and it shapes everything that follows. Confidential, unhurried.
About 10 minutesA single blood draw measuring prostate-specific antigen. This is the core of prostate screening — no discomfort beyond a needle, and the result is interpreted against your age rather than one universal number.
Under 5 minutesA digital rectal exam checks the gland's size, shape and texture — things a blood test cannot see. It takes under a minute and causes pressure rather than pain. If further detail is needed, we may recommend a transrectal ultrasound.
Under 2 minutesThere is no single normal PSA. What counts as raised at 45 is unremarkable at 70, which is why a result handed to you without interpretation is close to useless.
| Age range | Typical range | What it means for you |
|---|---|---|
| 40 – 49 | Under 2.5 ng/mL | Median is 0.6 – 0.7. A baseline here is your reference point for life. |
| 50 – 59 | Under 3.5 ng/mL | Annual testing from this point for most men. |
| 60 – 69 | Under 4.5 ng/mL | The years when screening changes outcomes most. |
| 70 – 79 | Under 6.5 ng/mL | Screening decisions become individual — discuss with your doctor. |
Early prostate cancer typically produces nothing at all. These signs more often point to an enlarged prostate than to cancer — but they are worth investigating rather than absorbing into daily life.
Straining to begin, or a flow that stops and restarts. The most common early complaint, and the one most often dismissed as ageing.
Two or more trips a night, particularly if this has changed over recent months.
Always warrants assessment, whatever the quantity and however briefly it appeared.
Both can have prostate involvement and both are treatable — the reluctance to raise them is the main obstacle.
Ongoing bone pain in these areas, especially alongside urinary changes, should be assessed promptly.
Feeling the bladder has not fully drained, or needing to go again shortly afterwards.
Standalone PSA testing across Kenyan laboratories generally falls in the range below. Prices vary by facility — call us for current URO-CARE pricing and insurance arrangements.
Teaching and referral hospital labs sit at the lower end. Longer waits, and the result usually arrives without interpretation.
Faster turnaround, often same-day. Still a number on a page unless you take it to a clinician who can place it in context.
Consultation, PSA and examination together, with a specialist urologist interpreting the result before you leave. Most major insurers accepted.
Men of African descent carry a higher risk of prostate cancer and tend to develop it earlier, so URO-CARE recommends starting the conversation at 40. If your father or brother has had prostate cancer, 40 is firm rather than optional. Men with no family history and no symptoms can reasonably begin annual screening at 50.
A standalone PSA blood test in Kenya generally runs between KES 1,500 and KES 5,000 depending on the facility, with public hospital laboratories at the lower end and private labs higher. At URO-CARE the PSA is done alongside a specialist consultation and examination, so you leave with the result interpreted rather than a number you have to decode alone. Call +254 112 268 709 for current pricing.
No. A digital rectal exam takes under a minute, causes brief pressure rather than pain, and is done privately with a lubricated gloved finger. Discomfort about this exam is the single most common reason Kenyan men delay screening — and it is the reason many present with advanced disease. The examination is far easier than most men expect.
Not usually. Only around one in four men with a raised PSA turn out to have prostate cancer. An enlarged prostate (BPH), prostatitis, a urinary infection, recent ejaculation and even long-distance cycling all push PSA up temporarily. That is exactly why the result needs a urologist to interpret — a single number in isolation causes needless alarm or false reassurance.
Avoid ejaculation and vigorous exercise, particularly cycling, for 48 hours before your blood draw — both can raise PSA temporarily. Tell your doctor about any medication you take, especially finasteride or dutasteride for an enlarged prostate or hair loss, since these roughly halve PSA readings.
Early-stage prostate cancer confined to the gland has excellent outcomes with treatment. The difficulty in Kenya is not treatment — it is timing. Studies at Kenyan referral hospitals have found the large majority of men presenting only once the disease has reached advanced stages, when options narrow considerably. Screening exists to move that timeline forward.
Difficulty starting urination, a weak or interrupted stream, waking repeatedly at night to urinate, blood in urine or semen, painful ejaculation, or persistent pain in the lower back, hips or pelvis. Early prostate cancer often causes no symptoms at all, which is why screening matters even when you feel completely well.
Confidential consultations with fellowship-trained urologists at URO-CARE, 3rd Parklands Avenue, Nairobi. Same-week appointments available — no referral needed.